Høydal MA, Kaurstad G, Rolim NP, Johnsen AB, Alves M, Koch LG, Britton SL, Stølen TO, Smith GL, Wisløff U. High inborn aerobic capacity does not protect the heart following myocardial infarction. J Appl Physiol 115: 1788 -1795, 2013. First published October 31, 2013 doi:10.1152 doi:10. /japplphysiol.00312.2013 is a strong prognostic marker for morbidity and mortality, but the cardio-protective effect of high inborn V O2max remains unresolved. We aimed to investigate whether rats with high inborn V O2max yield cardio-protection after myocardial infarction (MI) compared with rats with low inborn V O2max. Rats breed for high capacity of running (HCR) or low capacity of running (LCR) were randomized into HCR-SH (sham), HCR-MI, LCR-SH, and LCR-MI. V O2max was lower in HCR-MI and LCR-MI compared with respective sham (P Ͻ 0.01), supported by a loss in global cardiac function, assessed by echocardiography. Fura 2-AM loaded cardiomyocyte experiments revealed that HCR-MI and LCR-MI decreased cardiomyocyte shortening (39%, and 34% reduction, respectively, both P Ͻ 0.01), lowered Ca 2ϩ transient amplitude (37%, P Ͻ 0.01, and 20% reduction, respectively), and reduced sarcoplasmic reticulum (SR) Ca 2ϩ content (both; 20%, P Ͻ 0.01) compared with respective sham. Diastolic Ca 2ϩ cycling was impaired in HCR-MI and LCR-MI evidenced by prolonged time to 50% Ca 2ϩ decay that was partly explained by the 47% (P Ͻ 0.01) and 44% (P Ͻ 0.05) decrease in SR Ca 2ϩ -ATPase Ca 2ϩ removal, respectively. SR Ca 2ϩ leak increased by 177% in HCR-MI (P Ͻ 0.01) and 67% in LCR-MI (P Ͻ 0.01), which was abolished by inhibition of Ca 2ϩ /calmodulin-dependent protein kinase II. This study demonstrates that the effect of MI in HCR rats was similar or even more pronounced on cardiac-and cardiomyocyte contractile function, as well as on Ca 2ϩ handling properties compared with observations in LCR. Thus our data do not support a cardioprotective effect of higher inborn aerobic capacity.
HIGH AEROBIC CAPACITY MEASURED as maximal oxygen uptake (V O 2max ) is reported to reduce the risk of developing cardiovascular disease (CVD), regardless of reported activity level (28) , and is considered as an important prognostic parameter for patients with pronounced CVD (20, 22, 27, 36) . The inborn variation in V O 2max is determined by a complement of genes (24) , and heritability is estimated to predict ϳ50% of the V O 2max (6, 7) .
In 1996, Koch and Britton (25) started two-way artificial selective breeding to develop rat strains that only contrast for intrinsic (i.e., inborn) aerobic treadmill running capacity. After 11 generations of selection, the low-capacity runner (LCR) rats had developed features of the metabolic syndrome (48) and, in addition, cardiomyocyte properties with resembling characteristics, as previous observations in heart failure rats (19, 47, 48) . In contrast, the rats selected as high-capacity runner (HCR) rats displayed an athletic phenotype that included expansion of V O 2max . Subsequent work from generations 12-28 has revealed that the LCR score higher than the HCR for a wide range of complex disease risks, such as hepatic steatosis, increased susceptibility to ventricular fibrillation, and diminished longevity (26) . Thus this model is highly adequate for studying inborn effects of aerobic capacity on phenotype alterations.
Endurance training before and after myocardial infarction (MI) improves survival and restricts left ventricle (LV) remodeling (13, 15, 49) . It is, however, not known if the cardioprotective effect is restricted to acquired aerobic capacity by endurance training, or if inborn capacity may yield the same beneficial outcome.
We used the LCR and HCR rat model to determine the role of intrinsic (inborn) V O 2max on cardiac contractile function and Ca 2ϩ handling in LCR vs. HCR rats after MI by ligation of the left anterior descending coronary artery (LAD). We hypothesized that the higher aerobic capacity in HCR rats would yield a cardio-protective effect after MI compared with the LCR rats that already have established risk for CVD.
METHODS

Animals.
The rats used in the present study were selected and breed over 22 generations for either HCR or LCR starting from a N:NIH stock obtained from the National Institutes of Health (USA), as previously described (25, 48) . 1 In brief, the selection is based on an exercise capacity test at 11 wk of age, where rats with the 20% highest and 20% lowest scores are selected to generate the next generation for each strain. Concurrent breeding of HCR and LCR at every generation allows them to serve as reciprocal controls for unknown environmental changes. Female rats were randomized for sham (SH) or MI surgery, giving the following four groups: HCR-SH, HCR-MI, LCR-SH, and LCR-MI. The Norwegian council for Animal Research approved the study, which was in accordance with Use of Laboratory Animals Laboratory Animals by the European Commission Directive 86/609/EEC. MI surgery. MI was performed by permanent occlusion of LAD during 1.5% isoflurane anesthesia, and the success of inducing an permanent LAD occlusion was evaluated by echocardiography after 1 wk, as earlier described (23) . Following MI, the animals remained sedentary in their cages before they were killed after 12 wk. One week before sacrificing the animals, the rats were examined by echocardiography to determine cardiac function. We included rats with MI larger than 40% of the LV to ensure consistency in the study population. There were no differences in the number of excluded animals or infarct size between the HCR and LCR.
V O2max. All animals remained sedentary for 12 wk following the MI surgical procedure. At the end of the experimental period, we measured V O2max during uphill (25°) treadmill running in a metabolic chamber (48 before sacrificing the animals). The V O2max test procedure is a previously described and validated method (19, 46) .
Echocardiography. Echocardiography was measured by Vevo 770 VisualSonics (Toronto, Canada) during isoflurane (2%) anesthesia. LV end-diastolic diameter (LVEDD) and end-systolic diameter (LVESD) were recorded with parasternal long-axis B-mode echocardiography, which allowed calculation of the fractional shortening (FS) {% ϭ [(LVEDD Ϫ LVESD)/LVEDD] ϫ 100} as an index of systolic LV function.
Cardiomyocyte isolation, Ca 2ϩ measurements, and cardiomyocyte dimension measurements. The animals were killed during isoflurane (3%) anesthesia and heparinized (0.2 ml heparin) before removal of the heart. Cardiomyocytes from the LV were isolated by retrograde Langendorff perfusion and enzymatic digestion of collagenase (Worthington Biochemical), as previously described (18) . To ensure that we only studied viable cardiomyocytes remote from the ischemic infarct area, we removed both the infarct and the boarder zone area (ϳ1-2 mm from the boarder of the infarction). Cell experiments were performed in 1.8 mmol/l Ca 2ϩ HEPES-based solution. Cardiomyocytes were field stimulated by bipolar electrical pulses at 1-2 Hz in 1.8 mmol/l Ca 2ϩ HEPES-based solution and continuously perfused at 37°C. Cardiomyocyte shortening was measured by video-based sarcomere spacing (SarcLen Sarcomere Length Acquisition Module, Ionoptix, Milton, MA) using an inverted epifluorescence microscope (Nikon TE-2000E, Tokyo, Japan). Ca 2ϩ handling measurements by fura 2-AM (2 mol/l, Molecular Probes, Eugene, OR) was measured by a photomultiplier tube acquisition add-on module ( 2) addition of 10 mmol/l caffeine in normal HEPES 1.8 mmol/l Ca 2ϩ solution that offset the SR and re-uptake by SERCA-2a; and 3) addition of 10 mmol/l caffeine in a 0 Na ϩ /0 Ca 2ϩ solution that offset both SERCA-2a and NCX.
Confocal imaging of Ca 2ϩ release synchrony. Cardiomyocytes loaded with fluo 3-AM (10 mol/l, Molecular Probes) were used to determine Ca 2ϩ release synchrony. For the Ca 2ϩ release synchrony analysis, one to three Ca 2ϩ transients/cell were used, and the line scan of each Ca 2ϩ transient was divided into ϳ25 equal strips (ϳ4 m/strip). Time from stimulation to 50% Ca 2ϩ release was measured for each strip, and the standard deviation of the measurement was used as a measure of Ca 2ϩ release synchronicity across the cell. Statistics. Statistical analyses were performed by ANOVA using Bonferroni post hoc test. To determine whether there was a significantly more pronounced effect by MI between the two phenotypes (i.e., HCR and LCR), we performed an independent sample two-tailed t-test on the delta (⌬) change induced by MI between the LCR (LCR-SH Ϫ LCR-MI) and HCR (HCR-SH Ϫ HCR-MI). The use of "relative effect of MI" in this context is, therefore, used to show the ⌬ change occurring on each single parameter as a consequence of inducing MI in each line of animals (HCR and LCR). In these analyses, we have used the assumption that the sham animals are the zero point reference within the LCR and HCR groups.
Data are presented as means Ϯ SD. P Ͻ 0.05 was considered statistically significant.
RESULTS
Intrinsic aerobic capacity and in vivo cardiac contractility.
Aerobic capacity, measured as V O 2max , was significantly lower in LCR-SH compared with HCR-SH (P Ͻ 0.01, Fig. 1 ). V O 2max was reduced after MI in both HCR and LCR rats compared with their respective sham-groups (by 20 and 36%, respectively, P Ͻ 0.01, Fig. 1 ). Cardiac function measured by echocardiography demonstrated reduced systolic function after MI in both HCR and LCR rats (Table 1) HCR-MI (from 33% in HCR-SH to 17% in HCR-MI; P Ͻ 0.01, Table 1 ), and by 62% in LCR-MI (from 26% in LCR-SH to 10% in LCR-MI; P Ͻ 0.01, Table 1 ). MI induced a reduction in ejection fraction (EF) from 67 to 36% in HCR (P Ͻ 0.01, Table 1 ) and from 52 to 26% in LCR rats (P Ͻ 0.01, Table 1 ). LV end-systolic volume (LVESV) was increased after MI in both HCR and LCR by 130 and 116%, respectively (both P Ͻ 0.001, Table 1 ).
Cardiomyocyte size. Cardiomyocyte width and length were not significantly different between sham groups. MI induced a significant increase in cardiomyocyte width and length in both HCR and LCR rats (P Ͻ 0.01, Fig. 2, A and B) .
Cardiomyocyte contractility and Ca 2ϩ transients. LCR-SH was characterized by depressed cardiomyocyte contractile function and relaxation, as well as impaired Ca 2ϩ handling compared with HCR-SH (Fig. 3) . The relative reduction in cardiomyocyte FS was 39% in HCR-MI (P Ͻ 0.01, Fig. 3A ) and 34% in LCR-MI (P Ͻ 0.01, Fig. 3A ), compared with respective sham group. The ⌬ change induced by MI relative to their respective sham groups was significantly larger in HCR than LCR rats (P Ͻ 0.01, Fig. 3A) . Also, the ⌬ effect of MI on time to 50% relengthening during diastole was larger in HCR (P Ͻ 0.05, Fig. 3B ). Despite this larger effect of MI in HCR rats, it is important to note that time to 50% relengthening was still significantly faster than observed in LCR-MI (P Ͻ 0.01, Fig. 3B ) and not significantly different from LCR-SH. Ca 2ϩ transient amplitude was reduced by 37% in HCR after MI (P Ͻ 0.01, Fig. 3C ), whereas a 20% reduction was observed in LCR-MI rats (not significant, Fig. 3C ). Again, the ⌬ effect of MI relative to their respective sham was more pronounced in HCR than LCR rats (P Ͻ 0.05, Fig. 3C ). Similar to time to 50% relengthening, Ca 2ϩ decay during diastole was prolonged after MI in both HCR (P Ͻ 0.01, Fig. 3D ) and LCR (P Ͻ 0.01, Fig. 3D ). Ca 2ϩ decay was not different between HCR-MI and LCR-SH. Diastolic Ca 2ϩ levels were not different between any group (Fig. 3E) , whereas SR Ca 2ϩ content was higher in HCR-SH compared with all other groups (P Ͻ 0.01, Fig. 3F ). MI reduced SR Ca 2ϩ content with the same impact in HCR and LCR (both 20%, P Ͻ 0.01, Fig. 3F ).
To determine Ca 2ϩ release properties, we measured the time to 50% peak Ca 2ϩ amplitude and the Ca 2ϩ release synchrony along the cardiomyocyte length. We did not find any significant difference on time to 50% Ca 2ϩ amplitude between groups (Fig. 4A) . The difference for synchrony of Ca 2ϩ release was only different between HCR-MI and LCR-SH (Fig. 4B) .
Diastolic Ca 2ϩ handling. Since the transition from normal function to heart failure usually shift the Ca 2ϩ cycling distribution between SR and sarcolemmal Ca 2ϩ handling proteins (3), we quantified SERCA-2a and NCX rate of Ca 2ϩ removal during diastole. We found that SERCA-2a Ca 2ϩ removal rate was significant higher in HCR-SH compared with all other groups (P Ͻ 0.001, Fig. 5A ). After MI, SERCA-2a Ca 2ϩ removal decreased by 47% in HCR (P Ͻ 0.001, Fig. 5A ) and 44% in LCR (P Ͻ 0.05, Fig. 5A ) compared with respective sham. The ⌬ change relative to their respective sham groups on SERCA-2a Ca 2ϩ removal following an MI was largest in HCR (P Ͻ 0.05, Fig. 5A ). The reduction in SERCA-2a function resulted in a compensatory increase in NCX; the NCX rate constant of Ca 2ϩ removal in HCR was nonsignificantly increased by 27% as a response to MI, whereas it increased by 32% in LCR-MI rats compared with LCR-SH (P Ͻ 0.05, Fig.  5B ). These observations are consistent with the reduced SR Ca 2ϩ content observed in HCR-MI and LCR-MI cardiomyocytes (Fig. 3F) . It is, however, important to note that, despite the alteration in Ca 2ϩ removal rate by SERCA-2a and NCX in HCR-MI rats, these parameters were not significant different from LCR-SH.
Diastolic SR Ca 2ϩ leak. SR Ca 2ϩ leak was minor in HCR-SH, but increased by 177% after MI (from 2.6% RyR Ca 2ϩ leak in HCR-SH to 7.2% in HCR-MI, P Ͻ 0.01, Fig. 6A ). The diastolic SR Ca 2ϩ leak in LCR-SH was significantly larger compared with HCR-SH and was further increased by 67% after MI (from 6.1% in LCR-SH to 10.2% RyR Ca 2ϩ leak in LCR-MI, P Ͻ 0.01, Fig. 6A ). In heart failure, increased phosphorylation of the RyR by CamKII is shown to be a key mechanism for increased diastolic SR Ca 2ϩ leak (2); therefore, we incubated the cells with the CaMKII inhibitor, AIP. We found that diastolic SR Ca 2ϩ leak remained unchanged in HCR-SH, whereas it was normalized in HCR-MI, LCR-SH, and LCR-MI (Fig. 6B) . In addition, to evaluate the effect of PKA phosphorylation on Ca 2ϩ leak, we also incubated the cells with the PKA inhibitor, H-89, and found no significant effects (Fig. 6C) .
DISCUSSION
The objective of the present study was to investigate if contrasting for high or low inborn aerobic capacity would yield different remodeling on cardiac contractile function and Ca 2ϩ handling after MI; i.e., potential for cardio-protection in rats with high inborn aerobic capacity and, conversely, more severe deterioration in rats with low inborn aerobic capacity. We found that MI led to a severe reduction in V O 2max and LV function, as well as cardiomyocyte function and Ca 2ϩ handling in both of the groups. In contrast to our hypothesis, HCR rats with high inborn aerobic capacity suffered the same, or even a greater, loss after an MI than LCR rats on V O 2max , cardiac contractile function, and Ca 2ϩ handling properties when relating to the respective sham groups. However, rats with high inborn aerobic capacity displayed an advantageous end point outcome compared with their LCR counterparts as the cardiac function in HCR after MI was comparable to the shamoperated LCR for almost all parameters.
Aerobic capacity and global cardiac function after MI. As earlier reported, V O 2max was lower in LCR-SH compared with HCR-SH rats (48) . In the present study, V O 2max was reduced to the same extent in both animal lines after MI, which was explained by an equal deteriorated global cardiac contraction, assessed by reduced LV FS and EF. However, despite similar reduction on V O 2max and cardiac contraction when relating to their respective sham after MI in LCR and HCR, the levels from HCR-MI rats were still functionally higher than those of LCR-MI and similar to those of LCR-SH. Low EF is associated with ventricular enlargement after MI, or LV dilatation caused by infarct expansion (21, 35) . In addition to EF, LVESV is considered a meaningful prognosticator after MI, as it predicts the extent of LV remodeling (35) . We observed an equal increase in LVESV in both HCR and LCR after MI, suggesting similar prognosis. Accordingly, in vivo measurements of cardiac function indicated that high-inborn aerobic capacity was not associated with cardio-protective effects after MI in terms of reduced cardiac function and remodeling of the heart relative to their respective sham.
Cardiomyocyte contractility, relaxation, and Ca 2ϩ transients. Impaired global cardiac function is commonly mediated by diminished function of individual cardiomyocytes and dysfunctional Ca 2ϩ handling. Our laboratory has previously reported that cardiomyocytes from LCR rats resemble cardiomyocytes from post-MI failing hearts (19, 48) . In line with this, we found that LCR-SH had similar cardiomyocyte contractility and Ca 2ϩ handling as HCR-MI on most parameters. However, in contrast to our hypothesis, we observed that the HCR rats had a larger ⌬ reduction in cardiomyocyte FS and time to functional relengthening compared with their respective sham groups than the ⌬ reduction after MI in LCR rats.
The lower FS in HCR-MI, LCR-SH, and LCR-MI compared with HCR-SH was probably caused by the reduced Ca 2ϩ transient amplitude through depletion of the SR Ca 2ϩ content (4). Time to 50% Ca 2ϩ decay during diastole was also prolonged in these groups, leading to impaired cardiomyocyte relengthening.
The reduced time to 50% Ca 2ϩ decay, explained by lower rate constant of SERCA-2a Ca 2ϩ removal, probably partly caused the observed reduction in SR Ca 2ϩ content, leaving less Ca 2ϩ available for cardiomyocyte contraction (17) . Reduced SERCA-2a activity is usually accompanied by increased NCX activity, which is commonly seen in failing hearts (16, 30, 38 The RyR is directly phosphorylated by the multifunctional CaMKII (31) . In heart failure, CaMKII activity is increased, causing phosphorylation of RyR that may lead to spontaneous Ca 2ϩ release and afterdepolarizations of the ventricle (2) . By acutely inhibiting CaMKII with AIP in isolated cardiomyocytes, we found that SR Ca 2ϩ leak was abolished. In addition, we inhibited the effect of PKA, previously shown to increase the open probability of the RyR, causing increased Ca 2ϩ leak (32, 41) . We did, in contrast to those studies, not find any effect of PKA inhibition on SR Ca 2ϩ leak. The increased SR Ca 2ϩ leak appears, therefore, to be caused by CaMKII in the present study. As emphasized by other studies, CaMKII probably serves as an important target for preventing spontaneous Ca 2ϩ release that may trigger ventricular arrhythmias and additionally for rescuing defective Ca 2ϩ handling and hence cardiac function (43, 44) .
Cardioprotection by aerobic capacity appears to be exercise dependent. The data from the present study are not consistent with a cardio-protective effect of high inborn aerobic capacity; when comparing the change following MI relative to the respective sham groups the in vivo cardiac function, cardiomyocyte function and Ca 2ϩ handling were similar, or, even more profoundly, affected on several parameters in HCR than in LCR rats.
In 1980, Morris et al. (37) reported greater survival rate in fit compared with sedentary subjects after MI. Later, other experimental animal studies suggested that exercise training preconditions the heart and protects it against ischemia-reperfusion injury (8, 9, 12, 13, 29, 40, 50) , as well as promotes healing of the infarcted area (13, 33) . The protective role of a high V O 2max in relation to CVD morbidity and mortality may as such be a result of adaptive responses to exercise training that serve as cardiac preconditioning rather than by V O 2max level alone. Our data indicate, therefore, that high inborn V O 2max without the adaptive response to exercise training do not elicit the expected cardio-protective effect on MI tolerance, even though V O 2max is reported more closely related to mortality risk than physical activity levels per se (28, 34) . Thus cardio-protection is likely dependent on acute effects provided by exercise training, as it vanishes at cessation of regular exercise (29) .
It is difficult from our data to directly explain why high inborn aerobic capacity does not show the same protective effect as exercise training. A potential explanation for the lack of detectable protection in the present study is that the phenotypic changes developed through generation in rats selected for low aerobic capacity [including characteristics similar to the metabolic syndrome (22) ] may have triggered mechanisms that, to some extent, may precondition the heart against ischemic damage. These mechanisms were not explored in the present study, but previous studies with this model have shown that the immune response is exaggerated in LCR (45) , and especially TNF-␣ (14) and interleukin-10 (10), which have been show to have preconditioning effects on ischemia-reperfusion injury and is significantly upregulated in the LCR rats (26) .
Conclusion. This study demonstrates that the effect of MI in HCR rats was similar or even more pronounced on cardiac and cardiomyocyte contractile function, as well as on Ca 2ϩ handling properties, compared with observations in LCR. Thus our data do not support a cardio-protective effect of higher inborn aerobic capacity. The cardio-protective role associated with high aerobic capacity seems, therefore, not to depend on inborn characteristics, but rather on acquired aerobic capacity and cardiac preconditioning.
